Susan Catalano, founder and CSO of Cognition Therapeutics, speaks about Cognition’s clinical progress and the underlying rationale for its Alzheimer’s drug program . . .

Get GEN Edge Today!

See More on the Edge

Continue reading this article and more
with a GEN Edge subscription

Start Your 30-Day Free Trial Now

Log In Join GEN Edge